Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1340227 | 0.86 | TSHR (0.56) | PDK1TSHRCYP3A4ALDH1A1LMNA | |
| SCHEMBL14553750 | 0.85 | TSHR (0.59) | PDK1TSHRCYP3A4ALDH1A1LMNA | |
| SCHEMBL22897826 | 0.84 | ALDH1A1 (0.53) | TSHRCYP3A4ALDH1A1LMNAMAPT | |
| SCHEMBL29559314 | 0.84 | ALDH1A1 (0.53) | TSHRCYP3A4ALDH1A1LMNAMAPT | |
| SCHEMBL6809251 | 0.83 | PDK1 (0.58) | PDK1TSHRALDH1A1LMNAMAPT | |
| SCHEMBL29749825 | 0.83 | PDK1 (0.58) | PDK1TSHRALDH1A1LMNAMAPT | |
| SCHEMBL9687621 | 0.82 | TSHR (0.64) | TSHRCYP3A4ALDH1A1LMNAMAPT | |
| SCHEMBL14136388 | 0.81 | PDK1 (0.57) | PDK1TSHRCYP3A4ALDH1A1LMNA | |
| SCHEMBL19175613 | 0.81 | PDK1 (0.61) | PDK1TSHRALDH1A1LMNAMAPT | |
| SCHEMBL16958967 | 0.81 | PDK1 (0.57) | PDK1TSHRCYP3A4ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0365328-B1 | Pyridine derivatives | ZENECA LTD (GB) | 1996-04-03 | — | — | EP | claimed |
| US-5053415-A | Antiischemic, antiinflammatory, antiarthritic agents, cardiovascular disorders | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-10-01 | — | — | US | claimed |
| EP-0365328-A2 | Pyridine derivatives | ZENECA LIMITED (GB) | 1990-04-25 | — | — | EP | claimed |
| CN-118993987-A | Preparation method of 5-methyl-2-isopropoxy-4- (4-piperidine) -aniline dihydrochloride monohydrate | 广州科锐特生物科技有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-115215788-B | Preparation method of ceritinib key intermediate | 苏州凯瑞医药科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-115215788-A | Preparation method of ceritinib key intermediate | 苏州凯瑞医药科技有限公司 | 2022-10-21 | — | — | CN | disclosed |
| US-20180057457-A1 | Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof | NOVARTIS AG (CH) | 2018-03-01 | — | — | US | disclosed |
| WO-2016199020-A1 | PROCESS FOR PREPARATION OF CERITINIB | DR. REDDY'S LABORATORIES LIMITED (IN) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016199020-A1 | PROCESS FOR PREPARATION OF CERITINIB | DR. REDDY'S LABORATORIES LIMITED (IN) | 2016-12-15 | — | — | WO | disclosed |
| CN-106146387-A | The preparation method of ALK inhibitor | 湖北生物医药产业技术研究院有限公司 | 2016-11-23 | — | — | CN | disclosed |
| EP-2900645-A1 | 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION | Bayer CropScience AG (DE) | 2015-08-05 | — | — | EP | disclosed |
| CN-104803908-A | Hydrate of 2-isopropoxy-5-methyl-4-(4-piperidyl) aniline dihydrochloride as well as preparation method and application of hydrate | 2Y CHEM LTD | 2015-07-29 | — | — | CN | disclosed |
| CN-104447515-A | New intermediates for preparing ceritinib and preparation method of intermediate | 2Y CHEM LTD | 2015-03-25 | — | — | CN | disclosed |
| EP-0482771-B1 | Heterocyclic acids | ZENECA LTD (GB) | 1997-06-18 | — | — | EP | disclosed |
| EP-0365328-B1 | Pyridine derivatives | ZENECA LTD (GB) | 1996-04-03 | — | — | EP | disclosed |
| US-5410064-A | Thromboxane A2 antagonists and inhibitors of thromboxane A2 synthase | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-04-25 | — | — | US | disclosed |
| US-5219874-A | Heterocyclic acids | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-06-15 | — | — | US | disclosed |
| EP-0482771-A2 | Heterocyclic acids | ZENECA LIMITED (GB) | 1992-04-29 | — | — | EP | disclosed |
| US-5053415-A | Antiischemic, antiinflammatory, antiarthritic agents, cardiovascular disorders | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-10-01 | — | — | US | disclosed |
| EP-0365328-A2 | Pyridine derivatives | ZENECA LIMITED (GB) | 1990-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057457-A1 | Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof | PDXK, DCK, DPYD | PDK1 482/4885TSHR 1767/4885CYP3A4 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.